(Q80315123)
Statements
Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice (English)
Federica Sotgia
Franco Capozza
Elisabetta Gazzerro
Carlo Minetti
Michael P Lisanti